What a biopsy report should state before a surgical opinion
A pathology report is the document that tells a surgeon what kind of breast cancer is being treated. It is not a summary of your symptoms or a referral letter. The report should name the histological type, the grade of the tumour, and whether the sample was taken from the breast or from a lymph node. It should also state whether the margins are clear if the sample came from an excision rather than a needle biopsy.
This matters because breast-conserving surgery and mastectomy remove different amounts of breast tissue. The choice between them depends on the size and position of the tumour, the type of cancer, and what the patient wants. A report that only says "breast cancer" without the type, grade or sample site leaves the surgical team guessing. If your report is a short summary rather than the full pathology document, ask the hospital that performed the biopsy for the complete version, including any addendum or second opinion.
If the biopsy was done outside China, the report may be in another language. A certified translation is often requested before a Chinese hospital will review it. Ask the receiving hospital what format and language it needs, rather than assuming an English summary is enough.
Receptor status: the part that changes treatment direction
Receptor reports describe whether the cancer cells have oestrogen receptors, progesterone receptors, and HER2 protein. These results are usually reported separately from the main biopsy report, sometimes as an addendum. They matter because they determine whether hormone therapy or HER2-targeted treatment is relevant, and because they can affect whether surgery comes before or after systemic treatment.
A receptor report should state the percentage of cells that stain positive, not just "positive" or "negative". For HER2, it should state whether the result is positive, negative, or equivocal, and whether a confirmatory test such as in-situ hybridisation was performed. If your report says "equivocal" without a follow-up result, that is a gap the treating team will need to resolve.
If you have already started systemic therapy, the receptor status from the original biopsy may not reflect the current situation. A repeat biopsy may be needed, but that decision belongs to the treating clinician. Your job is to make sure the original report and any later biopsy reports are both available.
Previous systemic therapy: what the surgical team needs to know
If you have already received chemotherapy, hormone therapy, or HER2-targeted treatment, the surgical team needs a clear record of what was given, when it started and stopped, and how the tumour responded. This is not the same as a list of medicines. The team needs to know whether the treatment was given before surgery to shrink the tumour, after surgery, or for metastatic disease.
A response summary is useful: did the tumour shrink on imaging, stay stable, or grow? If the treatment was stopped early because of side effects, that should be recorded. If you are still receiving treatment, the surgical team needs to know the current regimen and the date of the last dose.
This information affects surgical planning. A tumour that has responded well to pre-operative treatment may be treated differently from one that has not. Without the treatment history, a surgeon cannot judge whether the planned operation is appropriate or whether further systemic treatment should come first. Bring the actual treatment records, not a verbal account.
Surgical extent and reconstruction: two separate decisions
The diagnosis report does not decide the operation. The surgical team decides the extent of surgery after reviewing the pathology, the imaging, your preferences, and your general health. Breast-conserving surgery removes the tumour and a margin of normal tissue; mastectomy removes the whole breast. These are different operations with different implications for follow-up and for reconstruction.
Reconstruction is a separate discussion. It may be done at the same time as the cancer operation or later, and it may involve implants, tissue from another part of the body, or both. Whether reconstruction is suitable depends on the cancer treatment plan, your health, and your preferences. The diagnosis report informs that discussion but does not determine it.
If you are considering care in China, ask the hospital whether the surgical and reconstructive teams work together and how they plan the sequence. Do not assume that reconstruction is automatically available or that it is included in the cancer surgery plan. Ask what the written plan covers and who will make the final decision.
What to send, and what to ask before a records review
For an initial enquiry, you do not need to send a complete medical archive. A short summary of the diagnosis, the date of the biopsy, the receptor results, and any treatment already received is enough for a first review. The team can then tell you what additional documents are needed.
When you send records, include the full pathology report with any addenda, the receptor report, imaging reports, and a list of treatments with dates. If a document is missing, say so rather than leaving it out. A records review can identify gaps, but it cannot fill them.
Ask the receiving hospital these questions in writing: What documents do you need for a surgical opinion? Do you need the original slides or blocks for pathology review? How do you handle reports in another language? What is the scope of the written estimate, and what is not included? These are administrative questions, and the answers should come from the hospital, not from a general guide.
Next step: a short summary first, not a full archive
The practical starting point is a short summary, not a complete archive. Write down the histological type, the grade, the sample site, the receptor results, and any systemic therapy you have already received with dates. Then state your main question in one sentence, for example whether the operation you have been offered is appropriate for the pathology described, or whether reconstruction is a separate discussion at the hospital you are considering. That summary is enough for a first review, and it lets the receiving team tell you what else it needs instead of asking you to send everything at once.
If a document is missing, name the gap rather than working around it. If the receptor report exists only as a one-line summary, say so. If the biopsy was reported abroad and the full document is in another language, say which language and whether a translation exists. If you have had treatment but no written response assessment, say that no imaging summary is available. These statements are more useful than a partial file, because they tell the reviewing team exactly which questions remain open and which documents to request from the original hospital.
Keep the clinical and administrative questions separate. The pathology question, the receptor question and the treatment-history question belong to the treating clinicians, who decide what the reports mean for your case. The document question, the language question and the estimate-scope question belong to the hospital or coordination office handling your enquiry. Mixing them produces vague answers. Ask each question of the right party, in writing, and keep the reply with your records.
When you contact a hospital or a coordination service, ask what the written estimate covers and what it does not, who issues it, and which department performs each part of the plan. Ask whether the surgical and reconstructive assessments are arranged as one discussion or two, and which clinician leads each. Ask what the hospital needs in order to review your pathology, including whether it wants the original slides or blocks. These are questions about that provider's own process, and only that provider can answer them accurately.
ChinaSpecialistCare can carry out a free initial review of the records you have, point out what appears to be missing, and suggest the relevant next step. That review is administrative and is not a diagnosis or a promise that a hospital will accept your case. A proxy consultation or multidisciplinary review is optional and is not a prerequisite for every appointment. The hospital and its clinicians decide whether to accept the case, what operation to recommend, and whether reconstruction is suitable.
The reason to sort the reports first is simple. The choice between breast-conserving surgery and mastectomy, and whether reconstruction is discussed at the same time or later, depends on the type of cancer, its extent, and the treatment already given. A team that cannot see those details cannot give you a meaningful opinion, and no amount of travel planning substitutes for them. Get the biopsy and receptor documents complete and readable, then ask your specific question of the specific provider.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.